Flonase Goes OTC
Written by Editor   
Tuesday, August 05, 2014 12:32 PM

The FDA has approved over-the-counter sales for Flonase (fluticasone propionate), the nasal spray for allergies, its manufacturer said.  It's the first intranasal steroid drug for allergies to be given OTC status.

GlaxoSmithKline, which sells Flonase Allergy Relief, said it expected to have the OTC version available for retail sale in early 2015. The dosage will be the same as in the current prescription product, the company said in a press release on Thursday. 

The OTC product's label will indicate that it provides temporary relief of major nasal and eye-related allergy symptoms, including runny nose, sneezing, nasal congestion, and watery and itchy eyes, according to GlaxoSmithKline.

Source:  http://www.medpagetoday.com/AllergyImmunology/Allergy/46925